Halozyme Therapeutics Inc. buy melinda
Start price
25.02.17
/
50%
€11.07
Target price
06.03.17
€12.63
Performance (%)
7.25%
End price
06.03.17
€11.87
Summary
This prediction ended on 06.03.17 with a price of €11.87. The BUY prediction by melinda finished with a performance of 7.25%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Halozyme Therapeutics Inc. | 5.328% | 5.328% | 48.438% | 58.242% |
| iShares Core DAX® | 1.195% | 2.111% | 17.166% | 16.919% |
| iShares Nasdaq 100 | 3.220% | -1.375% | 22.801% | 33.740% |
| iShares Nikkei 225® | 1.858% | 0.888% | 10.064% | -0.682% |
| iShares S&P 500 | 2.168% | 0.612% | 22.739% | 38.274% |
Comments by melinda for this prediction
In the thread Halozyme Therapeu. diskutieren
Verschiedene Rituximab subkutanen Blutkrebs
PDUFA 26. Juni 2017
Stopped prediction by melinda for Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€13.80
29.09.19
29.09.19
€30.00
04.11.21
04.11.21
155.29%
05.11.21
05.11.21
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€14.46
15.09.17
15.09.17
€20.75
18.09.17
18.09.17
4.83%
18.09.17
18.09.17
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€11.27
07.04.17
07.04.17
€12.63
21.04.17
21.04.17
6.57%
21.04.17
21.04.17
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€10.73
05.01.17
05.01.17
€12.63
10.01.17
10.01.17
19.66%
10.01.17
10.01.17